Evidence map›Paper›PMID 26513347›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2016

Bias in CFTR screening panels.

Patrick R Sosnay, Carlo Castellani, Christopher M Penland, Johanna M Rommens, Michelle Lewis, Karen S Raraigh, Mary Corey, Garry R Cutting

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The future of cystic fibrosis care: a global perspective.The Lancet. Respiratory medicine · 2020
    Review
  2. Article
  3. Response to Sosnay et al.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Patrick R SosnayMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.ORCID http://orcid.org/0000-0002-4798-6394
Carlo CastellaniCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Christopher M PenlandCystic Fibrosis Foundation, Bethesda, Maryland, USA.
Johanna M RommensProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-8732-825X
Michelle LewisMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Karen S RaraighMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Mary CoreyProgram in Child Evaluative Health Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
Garry R CuttingMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Funding

MOLECULAR GENETICS OF CYSTIC FIBROSISR01DK044003 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Garry R Cutting · 1991 to 2026
$6.7M
NIDDK NIH HHS R01 DK044003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansMutationCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID26513347
PMCPMC4816068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.